Blood

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Blood

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Blood

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Blood

Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR

Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Blood

Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR

Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia.

Blood

Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH

Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia.

Blood

Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.

Blood

Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.

Blood

Le DT, Kong N, Zhu Y, Lauchle JO, Aiyigari A, Braun BS, Wang E, Kogan SC, Le Beau MM, Parada L, Shannon KM

Pages